Developmental basis for filamin-A-associated myxomatous mitral valve disease
Author(s) -
Kimberly Sauls,
Annemarieke de Vlaming,
Brett S. Harris,
Katherine Williams,
Andy Wessels,
Robert A. Levine,
Susan A. Slaugenhaupt,
Richard L. Goodwin,
Luigi Michele Pavone,
Jean Mérot,
JeanJacques Schott,
Thierry Le Tourneau,
Thomas A. Dix,
Sean R. Jesinkey,
Yuanyi Feng,
Christopher A. Walsh,
Bin Zhou,
H. Scott Baldwin,
Roger R. Markwald,
Russell A. Norris
Publication year - 2012
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvs238
Subject(s) - filamin , cardiology , medicine , mitral valve , anatomy , biology , genetics , cytoskeleton , cell
We hypothesized that the structure and function of the mature valves is largely dependent upon how these tissues are built during development, and defects in how the valves are built can lead to the pathological progression of a disease phenotype. Thus, we sought to uncover potential developmental origins and mechanistic underpinnings causal to myxomatous mitral valve disease. We focus on how filamin-A, a cytoskeletal binding protein with strong links to human myxomatous valve disease, can function as a regulatory interface to control proper mitral valve development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom